ReviewOne health (Amsterdam, Netherlands)2025
Impact of open markets on zoonotic threats and antimicrobial resistance: A One Health concern.
Review in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Comparative genomic analysis of antimicrobial resistance and virulence in Escherichia coli isolated from pigeons and chickens in live poultry markets, Guiyang, China.Poultry science · 2026Article
- Detection and Characterization of ESBL-Producing and Carbapenem-Resistant Klebsiella pneumoniae in Ornamental Birds and Their Surrounding Environments.MicrobiologyOpen · 2026Article
- Molecular detection of CTX-M ESBL-encoding genes inOpen veterinary journal · 2026Article
- Operational zoonotic containment of Middle East respiratory syndrome coronavirus in Saudi Arabia: An implementation-oriented One Health genomic framework.Veterinary world · 2026Review
- Detection of theVeterinary world · 2026Article
- The role of gut microbiome in antimicrobial resistance transmission between companion animals and livestock: mechanisms, drivers, and One Health implications.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Open markets play a significant role in global food distribution, particularly in East and Southeast Asia, where fresh produce, seafood, and live animals are commonly sold. However, they pose significant public health risks by facilitating the transmission of zoonotic pathogens and contributing to the spread of antimicrobial resistance (AMR). High human-animal interactions, poor hygiene, and unregulated antimicrobial use contribute to the emergence and spread of resistant microorganisms. Despite these risks, the role of open markets in the spread of zoonotic pathogens and AMR has received limited attention. Thus, this review explores the possible mechanisms by which AMR may spread in open markets, the role of microbial genetic exchanges in the emergence of new resistant strains in these settings, and the zoonotic risks associated with the live animal trade. It also discusses strategies and future directions to mitigate these issues, emphasizing the urgency of taking the required One Health actions to minimize the spread of AMR and the zoonotic infections globally. These actions should include robust surveillance, regulatory measures, public health initiatives along with advocacy and training, all crucial for protecting global health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.